• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Clarivate Unveils Citation Laureates 2025 - Highlighting Nobel-Class Research with Global Impact

    9/25/25 3:00:00 AM ET
    $CLVT
    EDP Services
    Technology
    Get the next $CLVT alert in real time by email

    22 Researchers Recognized, Including First Citation Laureate Based in Mainland China

    LONDON, Sept. 25, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the Citation Laureates 2025 – a distinguished group of 22 researchers whose work is of Nobel class. Selected by experts at the Institute for Scientific Information (ISI) at Clarivate, these individuals have made pioneering contributions that are shaping the future of science and society.

    Clarivate logo (PRNewsfoto/Clarivate Analytics)

    Since the program's inception, 83 Citation Laureates have gone on to receive Nobel Prizes, often years after their initial recognition by Clarivate.

    Citation Laureates' foundational research papers rank among the most highly cited in their fields, reflecting exceptional influence across disciplines and borders. This year's Laureates have advanced knowledge in fields of urgent global relevance, including:

    • Physiology or Medicine: Leukemia, appetite regulation, and immune system research
    • Physics: Signal processing, quantum computing, interstellar chemistry, and image compression
    • Chemistry: Energy storage, green chemistry, sustainable energy, and cell engineering
    • Economics: Remote work, automation, inequality, poverty, and the economic impact of culture and discrimination

    The 2025 Laureates are affiliated with leading academic institutions in eight countries/regions. Ten are based in the United States, three in France, two each in Germany, Japan, and Switzerland, and one each in Canada, the Netherlands, and – for the first time – Mainland China.

    Tao Zhang, Academician of the Chinese Academy of Sciences and Professor at the Dalian Institute of Chemical Physics, is recognized for pioneering work in single-atom catalysis, a breakthrough that enables more efficient and sustainable chemical reactions. His selection as the first Citation Laureate based in Mainland China reflects the country's growing influence in global science. According to the latest G20 research and innovation scorecard from ISI, Mainland China led the G20 in research output in 2024 with nearly 900,000 papers — triple its 2015 volume.

    Tao Zhang, Academician of the Chinese Academy of Sciences and Professor at the Dalian Institute of Chemical Physics, said: "It is my great honor to receive the Citation Laureates 2025 award, which is a full recognition of the originality and international impact of our work. In the past, my collaborators and I created the concept of Single-Atom Catalysis by standing on the shoulders of others. Looking ahead, I hope that more young scientists will stand on our shoulders to drive catalysis and chemistry to a higher level. I believe that the integration of Single-Atom Catalysis with artificial intelligence will shape a new paradigm of atomically precise catalysis, making catalyst rational design possible and accelerating the advancement of global new energy and green chemical industries."

    Emmanuel Thiveaud, Senior Vice President for Research & Analytics, Academia & Government at Clarivate, said: "Each year, the Citation Laureates program highlights researchers whose work has transformed their disciplines and delivered profound societal impact. Their research is not only highly cited but deeply influential. At Clarivate, we are proud to honor these pioneers whose contributions often foreshadow Nobel recognition and help shape a better future."

    Since 2002, ISI analysts have used publication and citation data from the Web of Science Core Collection to identify potential Nobel Prize recipients. Out of 64 million articles and proceedings indexed since 1970, less than 0.02% have been cited more than 2,000 times. Citation Laureates are selected from this elite group through rigorous citation analysis and expert insight.

    The Citation Laureates 2025 are:

    Physiology or Medicine

    Andrea Ablasser, Professor, Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland

    Glen N. Barber, Professor, Department of Surgery/Div Surg Oncology, Klotz Chair in Cancer Research, and Director of the Center for Innate Immunity and Inflammation, Pelotonia Institute for Immuno-Oncology, The James Cancer Center, Ohio State University, Columbus, Ohio, United States

    Zhijian 'James' Chen, George L. MacGregor Distinguished Chair in Biomedical Science, Director of the Inflammation Research Center, and Professor of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, United States; Howard Hughes Medical Institute Investigator

    "for elucidating the cGAS-STING pathway, a fundamental mechanism of innate immunity"

    John E. Dick, Senior Scientist, Princess Margaret Cancer Centre, and Helga and Antonio De Gasperis Chair in Blood Cancer Stem Cell Research, University Health Network; Professor, Department of Molecular Genetics, and University Professor, University of Toronto, Toronto, Canada

    "for identifying leukemia stem cells and establishing their relevance in therapy failure and disease recurrence, thereby shifting the focus for many types of cancer and their treatments"

    Kenji Kangawa, Former Director General of the Research Institute, National Cerebral and Cardiovascular Center, Osaka, Japan

    Masayasu Kojima, Professor Emeritus, Institute for Molecular Biosciences, Institute of Life Science, Kurume University, Kurume, Fukuoka, Japan

    "for discovery of ghrelin, a hormone regulating appetite, energy, and metabolism"

    Physics

    Ingrid Daubechies, James B. Duke Distinguished Professor Emerita of Mathematics, Duke University, Durham, North Carolina, United States

    Stéphane Mallat, Professor, Chair of Data Sciences, Collège de France, Paris, France

    Yves Meyer, Professor Emeritus of Mathematics, École Normale Supérieure Paris-Saclay, Paris, France

    "for advancing wavelet theory, a revolution in mathematics and physics with practical applications including image processing"

    David P. DiVincenzo, Director, Institute of Theoretical Nanoelectronics, Peter Grünberg Institute, Forschungszentrum Jülich, Jülich, Germany; Professor, Institute for Quantum Information, RWTH Aachen University, Aachen, Germany

    Daniel Loss, Professor, Theoretical Physics, Director of the Center for Quantum Computing and Quantum Coherence (QC2), and Co-Director of National Center on Spin Qubits (NCCR SPIN), University of Basel, Basel, Switzerland

    "for proposing the Loss-DiVincenzo model for quantum computing, using electron spins in quantum dots as qubits"

    Ewine F. van Dishoeck, Professor of Molecular Astrophysics, Leiden University, Leiden, The Netherlands; External Scientific Member, Max Planck Institute for Extraterrestrial Physics, Garching, Germany

    "for pioneering contributions to astrochemistry revealing interstellar molecular clouds and their role in star and planet formation"

    Chemistry

    Clifford P. Brangwynne, Director, Omenn-Darling Bioengineering Institute, June K. Wu '92 Professor in Engineering, and Professor of Chemical and Biological Engineering, Princeton University, Princeton, New Jersey, United States; Howard Hughes Medical Institute Investigator

    Anthony A. Hyman, Director and Research Group Leader, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany

    Michael K. Rosen, Mar Nell and F. Andrew Bell Distinguished Chair of the Biophysics Department, Investigator of the Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas, United States

    "for discoveries on the role of phase-separated biomolecular condensates in biochemical organization of the cell"

    Jean-Marie Tarascon, Professor of Chemistry, Collège de France, Paris, France

    "for fundamental advances and novel applications in energy storage and conversion technology"

    Tao Zhang, Academician of Chinese Academy of Sciences, and Professor, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, Mainland China

    "for seminal contributions to the development of Single-Atom Catalysis and applications"

    Economics

    David Autor, Daniel (1972) and Gail Rubinfeld Professor, Department of Economics, MIT, Cambridge, Massachusetts, United States

    Lawrence F. Katz, Elisabeth Allison Professor of Economics, Department of Economics, Harvard University, Cambridge, Massachusetts, United States

    "for seminal analysis of wage structure, earnings inequality, educational advance, and technological change"

    Marianne Bertrand, Chris P. Dialynas Distinguished Service Professor of Economics, University of Chicago Booth School of Business, Chicago, Illinois, United States

    Sendhil Mullainathan, Peter de Florez Professor, Electrical Engineering and Computer Science and Economics (Dual Appointment), MIT, Cambridge, Massachusetts, United States

    "for joint research on racial discrimination, corporate governance, and other aspects of labor economics determined by psychology and culture"

    Nicholas Bloom, William Eberle Professor of Economics, Department of Economics, Stanford University, Stanford, California, United States

    "for analyzing the impact of economic and political uncertainty on investment, employment and growth"

     

    While the Citation Laureates program does not aim to predict Nobel Prize recipients in a specific year, it highlights researchers whose work is of Nobel class and deserving of global recognition.

    Notes to editors:

    • Learn more about the Citation Laureates selection methodology and explore the research contributions of this year's Laureates on the Clarivate blog.
    • View the full list of Citation Laureates named since 2002 in the Hall of Citation Laureates.
    • David Pendlebury, Head of Research Analysis at the Institute for Scientific Information at Clarivate, is available for interview.
    • The 2025 Nobel Prize announcements will take place from 6–13 October and will be streamed live at www.nobelprize.org.

    About Clarivate

    Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

    Media contact:

    Rebecca Krahenbuhl, Senior Manager, External Communications, Academia & Government

    [email protected] 

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-unveils-citation-laureates-2025--highlighting-nobel-class-research-with-global-impact-302566388.html

    SOURCE Clarivate Plc

    Get the next $CLVT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CLVT

    DatePrice TargetRatingAnalyst
    9/3/2025Peer Perform
    Wolfe Research
    7/18/2025$4.50Buy → Hold
    Jefferies
    11/6/2024Outperform → Mkt Perform
    William Blair
    12/15/2023$8.00Equal Weight → Underweight
    Wells Fargo
    10/16/2023$10.00 → $8.50Hold → Buy
    Jefferies
    9/8/2023$8.00 → $7.00Equal Weight → Underweight
    Barclays
    8/25/2023$9.00 → $8.00Outperform → Sector Perform
    RBC Capital Mkts
    8/7/2023$10.00 → $6.00Neutral → Underperform
    BofA Securities
    More analyst ratings

    $CLVT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cornick Kenneth L. bought $617,100 worth of Ordinary Shares (165,000 units at $3.74) (SEC Form 4)

    4 - CLARIVATE PLC (0001764046) (Issuer)

    8/5/25 4:13:31 PM ET
    $CLVT
    EDP Services
    Technology

    Director Snyder Andrew Miles bought $989,024 worth of Ordinary Shares (237,176 units at $4.17) (SEC Form 4)

    4 - CLARIVATE PLC (0001764046) (Issuer)

    3/18/25 4:56:10 PM ET
    $CLVT
    EDP Services
    Technology

    Director Bomba Jane L Okun bought $200,492 worth of Ordinary Shares (49,750 units at $4.03) (SEC Form 4)

    4 - CLARIVATE PLC (0001764046) (Issuer)

    3/14/25 4:14:29 PM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, IP Mourad Maroun S. was granted 539,568 units of Ordinary Shares (SEC Form 4)

    4 - CLARIVATE PLC (0001764046) (Issuer)

    9/16/25 6:06:09 PM ET
    $CLVT
    EDP Services
    Technology

    New insider Mourad Maroun S. claimed ownership of 105,000 units of Ordinary Shares (SEC Form 3)

    3 - CLARIVATE PLC (0001764046) (Issuer)

    9/16/25 5:38:49 PM ET
    $CLVT
    EDP Services
    Technology

    President, LS&H Levy Henry covered exercise/tax liability with 70,746 units of Ordinary Shares, decreasing direct ownership by 9% to 679,920 units (SEC Form 4)

    4 - CLARIVATE PLC (0001764046) (Issuer)

    8/15/25 4:55:10 PM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    SEC Filings

    View All

    Clarivate Plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - CLARIVATE PLC (0001764046) (Filer)

    8/5/25 4:14:50 PM ET
    $CLVT
    EDP Services
    Technology

    SEC Form S-8 filed by Clarivate Plc

    S-8 - CLARIVATE PLC (0001764046) (Filer)

    7/31/25 4:26:14 PM ET
    $CLVT
    EDP Services
    Technology

    Clarivate Plc filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CLARIVATE PLC (0001764046) (Filer)

    7/30/25 6:25:36 AM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wolfe Research initiated coverage on Clarivate

    Wolfe Research initiated coverage of Clarivate with a rating of Peer Perform

    9/3/25 8:37:02 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate downgraded by Jefferies with a new price target

    Jefferies downgraded Clarivate from Buy to Hold and set a new price target of $4.50

    7/18/25 8:08:08 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate downgraded by William Blair

    William Blair downgraded Clarivate from Outperform to Mkt Perform

    11/6/24 8:22:43 AM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Financials

    Live finance-specific insights

    View All

    Clarivate Reports Second Quarter 2025 Results

    — Continued acceleration of organic ACV and recurring organic revenue growth — — Delivered improved organic recurring revenue mix — — Reaffirmed 2025 Outlook — — Repurchased 11.5 million ordinary shares in the second quarter— LONDON, July 30, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the second quarter ended June 30, 2025. Total revenues for the second quarter of 2025 were $621.4 million, compared to total revenues of $650.3 million for the second quarter o

    7/30/25 6:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate to Report Second Quarter 2025 Results on July 30, 2025

    LONDON, July 8, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the second quarter 2025 before the market opens on Wednesday, July 30, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 9:00 AM Eastern Time on Wednesday, July 30, 2025 to review the results. The webcast is open to all interest

    7/8/25 7:30:00 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate Reports First Quarter 2025 Results

    — Accelerated recurring organic revenue growth — — Reaffirmed 2025 Outlook — — Repurchased $50 million ordinary shares — LONDON, April 29, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the first quarter ended March 31, 2025. Total revenues for the first quarter of 2025 was $593.7 million, compared to total revenues of $621.2 million for the first quarter of 2024. Organic revenues for the first quarter of 2025 increased 0.3%, compared to the first quarter of 202

    4/29/25 6:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Leadership Updates

    Live Leadership Updates

    View All

    Clarivate Announces Maroun S. Mourad as President, Intellectual Property

    LONDON, July 30, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced that Maroun S. Mourad will join the Company as President of the Intellectual Property (IP) segment, effective September 8, 2025. Maroun most recently served as President of the Claims Solutions division of Verisk Analytics Inc. He succeeds Gordon Samson, who will retire at the end of 2025 after a high-impact career in the IP industry, spending five years as the Chief Operating Officer at CPA Global, before joining the Clarivate executive team, most recently as the President of the IP segment.

    7/30/25 6:01:00 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate Appoints Henry Levy as President, Life Sciences & Healthcare

    Concludes the appointments for business leaders of its three market segments LONDON, April 26, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, announced today that it has appointed Henry Levy as President, Life Sciences & Healthcare, effective May 1, 2023. Henry joins from Veeva Systems, a global leader in cloud software for the life sciences industry, where he most recently served as President, Global R&D and Quality, with responsibility for driving sales across the segment. Jonathan Gear,

    4/26/23 7:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate Names Bar Veinstein as President, Academia & Government

    Appointing the second of three business leaders for its newly created market segments LONDON, April 19, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Bar Veinstein will join the company as President, Academia & Government, effective April 24, 2023. Bar joins from Taranis, an AI-powered crop intelligence provider, where he was Chief Executive Officer focusing on driving business growth, improving customer satisfaction and accelerating the company's artificial intelligence (AI) strategy. He previously spent 11 years with the Ex Libris Group, now part of Clarivate, and under his leader

    4/19/23 7:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Clarivate Plc

    SC 13G/A - CLARIVATE PLC (0001764046) (Subject)

    12/5/24 10:02:09 AM ET
    $CLVT
    EDP Services
    Technology

    SEC Form SC 13G filed by Clarivate Plc

    SC 13G - CLARIVATE PLC (0001764046) (Subject)

    11/13/24 4:18:30 PM ET
    $CLVT
    EDP Services
    Technology

    SEC Form SC 13D/A filed by Clarivate Plc (Amendment)

    SC 13D/A - CLARIVATE PLC (0001764046) (Subject)

    3/4/24 9:01:44 AM ET
    $CLVT
    EDP Services
    Technology

    $CLVT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Clarivate Unveils Citation Laureates 2025 - Highlighting Nobel-Class Research with Global Impact

    22 Researchers Recognized, Including First Citation Laureate Based in Mainland China LONDON, Sept. 25, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the Citation Laureates 2025 – a distinguished group of 22 researchers whose work is of Nobel class. Selected by experts at the Institute for Scientific Information (ISI) at Clarivate, these individuals have made pioneering contributions that are shaping the future of science and society. Since the program's inception, 83 Citation Laureates have gone on to

    9/25/25 3:00:00 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate Releases 2024 Sustainability Report

    Annual Report Highlights Achievements in Advancing the UN SDGs LONDON, Sept. 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released its 2024 sustainability report, highlighting the company's achievements in driving sustainability and broader Environment, Social and Governance (ESG) principles over the past year. This annual report demonstrates how Clarivate continues to focus on aligning its products and services with the United Nations Sustainable Goals (UN SDGs), contributing to progress across all 17 of these goals.

    9/18/25 4:18:00 AM ET
    $CLVT
    EDP Services
    Technology

    Clarivate to Present at the Goldman Sachs Communacopia + Technology Conference on September 11

    LONDON, Sept. 4, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today that Jonathan Collins, Executive Vice President and Chief Financial Officer, will present at the Goldman Sachs Communacopia + Technology Conference, on Thursday, September 11, 2025 at 8:50 am Pacific Time (11:50 am Eastern Time). The live webcast can be accessed at https://event.webcasts.com/starthere.jsp?ei=1731248&tp_key=0253632af4&tp_special=8 and will be available for replay. A replay of the webcast will also be available on https://ir.

    9/4/25 8:00:00 AM ET
    $CLVT
    EDP Services
    Technology